LiveVox Holdings OverviewLiveVox Holdings Research & Development
Research & Development expenses for CRSA.
Quarterly R&D Expenses
$7.34M
↓ 2.82% YoY
As of Sep 30, 2023
Annual R&D Expenses (TTM)
$29.42M
Trailing 12 months ending Sep 30, 2023
LiveVox Holdings OverviewResearch & Development expenses for CRSA.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023